Drug Sensitivity to Bedaquiline of M. kansasii Strains Isolated in Antituberculous Institutions of the City of Moscow
Relevance. M. kansasii are one of the main nontuberculous bacteria pathogens causing mycobacterial infections in most European countries (including Russia). An important problem in the treatment of mycobacteriosis is the resistance of their pathogens to antibacterial drugs (ABDs). Bedaquiline (Bdq)...
Saved in:
| Main Authors: | M. V. Makarova, Yu. D. Mikhajlova, E. N. Khachaturiants, V. I. Litvinov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Numikom LLC
2023-07-01
|
| Series: | Эпидемиология и вакцинопрофилактика |
| Subjects: | |
| Online Access: | https://www.epidemvac.ru/jour/article/view/1826 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bedaquiline Effect on QT Interval of Drugs-Resistant Tuberculosis Patients: Real World Data
by: I Gusti Agung Ayu Putu Sri Darmayani, et al.
Published: (2022-09-01) -
Bedaquiline practice in treatment of extensively drug-resistant mycobacterium tuberculosis in children: Clinical cases
by: A. A. Akzhigitova, et al.
Published: (2022-05-01) -
Investigation of delamanid, bedaquiline, and linezolid resistance rates and related gene mutations in multidrug-resistant Mycobacterium tuberculosis in regional tuberculosis reference laboratories of Iran
by: Nazanin Ahmad Khosravi, et al.
Published: (2025-08-01) -
Hepatic safety of pretomanid- and pyrazinamide-containing regimens in TB Alliance clinical trials
by: J. Nedelman, et al.
Published: (2025-08-01) -
CHLORIDE-2-[(1Z)-1-(3,5-DIPHENYL-1,3,4-THYADIAZOLE-2(3H)-ILIDEN)METHYL]-3,5-DIPHENYL-1,3,4-THYADIAZOLE-3 AS A PROMISING COMPOUND FOR THE DEVELOPMENT OF NEW DRUGS
by: A. S. Koshevenko, et al.
Published: (2019-01-01)